Literature DB >> 15225901

Decreased interleukin-1 receptor antagonist response following moderate exercise in patients with colorectal carcinoma after primary treatment.

Hubert Allgayer1, Susanne Nicolaus, Stephan Schreiber.   

Abstract

Clinical and experimental studies have shown that a moderately increased physical activity level may have beneficial effects in terms of exercise conditioning, resistance to infection and decreased relative risk of cancer. Modulation of the innate and adaptive components of the immune system with a shift of cytokines and their antagonists to a more pro- and less anti-inflammatory response was found to be a prominent feature in non-tumor patients and healthy volunteers. As quantitative data concerning the cytokine/antagonist response following exercise are not available for tumor patients, we compared the effects of a post-operative rehabilitation program with moderate exercise (ME) intensity (0.55-0.65 x maximal aerobic power) with a program with low exercise (LE) intensity (0.30-0.40 x maximal aerobic power) in patients with curatively treated colorectal carcinoma (UICC II and III) measuring pro- (IL-1beta, IL-6, tumour necrosis factor (TNF)) and anti-inflammatory cytokines (IL-1 receptor antagonist, sTNF receptors I and II). Twenty-three patients participated in this prospective trial, N = 13 in the ME group, N = 10 in the LE group. Exercise was performed daily 30-40 min for 2 weeks. Basal (circulating) and LPS-stimulated (phasic) cytokine and antagonist response was determined before exercise and after 1 and 2 weeks using appropriate ELISA tests. The LPS-stimulated interleukin-1 receptor antagonist (IL-1ra) response in the ME group gradually decreased from 31,532.6 (160.0-70,028.0) to 18,033.0 pg/ml (5040.0-52,570.0) after one and to 22,892.0 pg/ml (6376.0-34,726.0) after 2 weeks (P < 0.05) with a concomitant decrease of the corresponding IL-1ra/IL-6 and IL-1ra/IL-1beta ratio: 2.51-1.41 and 4.1-3.1, respectively. In contrast, in the LE group LPS-stimulated cytokines and antagonists did not significantly change during exercise. Circulating cytokines and antagonists remained unchanged in both groups. In providing quantitative data in patients with curatively-treated colorectal cancer, we demonstrated that a short-term rehabilitation program with moderate exercise leads to a decreased LPS-induced antagonist response with a shift to a more pro-inflammatory state (decreased antagonist/cytokine ratio). Whether this change of the phasic immune response to moderate exercise may be clinically beneficial (decreased rates of infection, relapses and/or second tumours) is possible, but has to be investigated in long-term studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225901     DOI: 10.1016/j.cdp.2004.02.001

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  27 in total

1.  Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.

Authors:  Lianqi Liu; Paul J Mills; Michelle Rissling; Lavinia Fiorentino; Loki Natarajan; Joel E Dimsdale; Georgia Robins Sadler; Barbara A Parker; Sonia Ancoli-Israel
Journal:  Brain Behav Immun       Date:  2012-03-02       Impact factor: 7.217

2.  The influence of high-intensity compared with moderate-intensity exercise training on cardiorespiratory fitness and body composition in colorectal cancer survivors: a randomised controlled trial.

Authors:  James L Devin; Andrew T Sax; Gareth I Hughes; David G Jenkins; Joanne F Aitken; Suzanne K Chambers; Jeffrey C Dunn; Kate A Bolam; Tina L Skinner
Journal:  J Cancer Surviv       Date:  2015-10-19       Impact factor: 4.442

Review 3.  Effects and potential mechanisms of exercise training on cancer progression: a translational perspective.

Authors:  Allison S Betof; Mark W Dewhirst; Lee W Jones
Journal:  Brain Behav Immun       Date:  2012-05-17       Impact factor: 7.217

Review 4.  An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.

Authors:  Rebecca M Speck; Kerry S Courneya; Louise C Mâsse; Sue Duval; Kathryn H Schmitz
Journal:  J Cancer Surviv       Date:  2010-01-06       Impact factor: 4.442

Review 5.  The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.

Authors:  Amikar Sehdev; Bert H O'Neil
Journal:  Curr Treat Options Oncol       Date:  2015-09

6.  Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.

Authors:  Mai Yamauchi; Paul Lochhead; Yu Imamura; Aya Kuchiba; Xiaoyun Liao; Zhi Rong Qian; Reiko Nishihara; Teppei Morikawa; Kaori Shima; Kana Wu; Edward Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Andrew T Chan; Shuji Ogino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-29       Impact factor: 4.254

Review 7.  Exercise, inflammation, and fatigue in cancer survivors.

Authors:  Emily C P LaVoy; Christopher P Fagundes; Robert Dantzer
Journal:  Exerc Immunol Rev       Date:  2016       Impact factor: 6.308

Review 8.  Colorectal cancer survivorship: movement matters.

Authors:  Crystal S Denlinger; Paul F Engstrom
Journal:  Cancer Prev Res (Phila)       Date:  2011-04

9.  Recommendations for high-priority research on cancer-related fatigue in children and adults.

Authors:  Andrea M Barsevick; Michael R Irwin; Pamela Hinds; Andrew Miller; Ann Berger; Paul Jacobsen; Sonia Ancoli-Israel; Bryce B Reeve; Karen Mustian; Ann O'Mara; Jin-Shei Lai; Michael Fisch; David Cella
Journal:  J Natl Cancer Inst       Date:  2013-09-18       Impact factor: 13.506

Review 10.  Physical activity before and after diagnosis of colorectal cancer: disease risk, clinical outcomes, response pathways and biomarkers.

Authors:  David J Harriss; N Tim Cable; Keith George; Thomas Reilly; Andrew G Renehan; Najib Haboubi
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.